Health Maintenance Organization–mHealth Versus Face-to-Face Interaction for Health Care in Israel: Cross-Sectional Web-Based Survey Study
Journal of Medical Internet Research · 2024
DOI: 10.2196/55350 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Medical Internet Research, 2024. Verfasst von Avi Zigdon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Systems Management, School of Health Sciences, Ariel University, Ariel, Israel. Hauptthemen laut MEDLINE: Telemedicine, Health Maintenance Organizations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Health maintenance organization–mobile health (HMO-mHealth) services have a direct impact on patients’ daily lives, and HMOs regularly expand their range of mHealth services. HMO-mHealth apps are saving HMOs time and money, as services are becoming more accessible to patients. However, the willingness to use mHealth apps depends on user perception. Although mHealth apps can change the relationship dynamic between HMOs and patients, patients prefer to use them to facilitate face-to-face interactions rather than replace them.
Objective
This study aims to examine the extent to which Israeli adults prefer adopting health care services using HMO-mHealth as a replacement for face-to-face interaction.
Methods
Israeli adults aged ≥18 years completed an electronic questionnaire. Data were collected from December 2020 to February 2021. All services in the main HMO-mHealth apps of the 4 Israeli HMOs were mapped. The 29 health care services used in this study were identical in all 4 HMO-mHealth apps in Israel. The association between sociodemographic characteristics and health condition with preference for HMO-mHealth or face-to-face interaction was analyzed separately for each health service by using a logistic model.
Results
A total of 6321 respondents completed the questionnaire (female: 4296/6321, 68%; male: 2025/6321, 32%). Approximately 80.9% (5115/6321) to 88.2% (5578/6321) of the respondents preferred using HMO-mHealth apps for administrative matters. However, 55.3% (3498/6321), 52.2% (3301/6321), and 46.9% (2969/6321) preferred face-to-face meetings for the initial medical diagnosis, medical treatment, and medical diagnosis results, respectively. Seven main variables were found to be associated with HMO-mHealth adoption, including gender, age, education, marital status, religious affiliation, and subjective health condition. Female respondents were more likely than male respondents to prefer HMO-mHealth apps for administrative matters and face-to-face interaction for personal medical diagnosis and treatment (odds ratio [OR] 0.74, 95% CI 0.67-0.83; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Systems Management, School of Health Sciences, Ariel University, Ariel, Israel.
- Department of Economics and Business Administration, Ariel University, Ariel, Israel.
- Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
ORCID-Profile: Avi Zigdon, Moti Zwilling, Ofek Zigdon, Orna Reges
Zitieren
APA
Zigdon, A., Zwilling, M., Zigdon, O., & Reges, O. (2024). Health Maintenance Organization–mHealth Versus Face-to-Face Interaction for Health Care in Israel: Cross-Sectional Web-Based Survey Study. Journal of Medical Internet Research. https://doi.org/10.2196/55350
Vancouver
Zigdon A, Zwilling M, Zigdon O, Reges O. Health Maintenance Organization–mHealth Versus Face-to-Face Interaction for Health Care in Israel: Cross-Sectional Web-Based Survey Study. Journal of Medical Internet Research. 2024. doi:10.2196/55350
BibTeX
@article{Zigdon2024,
author = {Zigdon, Avi and Zwilling, Moti and Zigdon, Ofek and Reges, Orna},
title = {Health Maintenance Organization–mHealth Versus Face-to-Face Interaction for Health Care in Israel: Cross-Sectional Web-Based Survey Study},
journal = {Journal of Medical Internet Research},
year = {2024},
doi = {10.2196/55350}
}
EUVIMED